Status:
UNKNOWN
Cohort of Patients Infected With SARS-CoV2 (COVID-19) or Suspected of Being
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
On 17th March 2020, 198 193 confirmed cases (7 730 in France) of COVID-19 infections and 7 854 deaths (175 in France) have been reported from 8th December 2019 in 157 countries. The rapid increase in ...
Detailed Description
The principal goal of the research is to assess the prognostic factors of the progression toward severe forms of the COVID-19 infection. The secondary aims of the study are to contribute to answer so...
Eligibility Criteria
Inclusion
- Age ≥ 18
- Patient admitted in an emergency unit or hospitalized, infected with SARS-CoV2 or suspected of being (the recruitment can occured during acute episode or during a follow-up visit)
- Written informed consent or emergency procedure
- Affiliated to health insurance system
Exclusion
- Refusal of participation
- Patient under justice protection measure except guardianship and trusteeship
Key Trial Info
Start Date :
March 31 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2022
Estimated Enrollment :
2003 Patients enrolled
Trial Details
Trial ID
NCT04352348
Start Date
March 31 2020
End Date
May 31 2022
Last Update
July 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GH Pitié-Salpêtrière / Service d'Accueil des Urgences
Paris, Île-de-France Region, France, 75013